Prostate-cancer testing not advised for older men
The new guidelines, issued by the U.S. Preventive Services Task Force, represent an abrupt policy change by an influential panel that had withheld any advice regarding screening for prostate cancer, citing a lack of reliable evidence. Though the task force still has not taken a stand on the value of screening in younger men, the shift is certain to reignite the debate about the appropriateness of prostate cancer screening at any age.
Screening for prostate cancer is typically performed with a blood test measuring prostate-specific antigen, or PSA, levels. Widespread PSA testing has led to high rates of prostate cancer detection. Last year, more than 218,000 men were diagnosed with the disease.
Yet various studies suggest the disease is "overdiagnosed" that is, detected at a point when the disease likely would not affect life expectancy in 29 percent to 44 percent of cases. Prostate cancer often progresses very slowly, and a large number of these cancers discovered through screening likely will never cause symptoms during the patient's lifetime, particularly if that patient is older. Aggressive treatment of prostate cancer can greatly reduce a patient's quality of life, resulting in such complications as impotency and incontinence.
The task force was created by Congress to analyze current medical research and to make recommendations about preventive care for healthy people.
"When you look at screening, you have a chance the screening will help you live longer or better, and you have the chance that screening detection and treatment will harm you," said Dr. Ned Calonge, chair of the task force and chief medical officer for the Colorado Department of Public Health and Environment. "At age 75, the chances are great that you'll have negative impacts from the screening."
Recent comments
I am 72 and have yearly PSA tests. I think the information coming…
Dallas Senior | Aug. 6, 2008 at 10:56 a.m.


